Roche Reveals Impact Of Multisource Biosimilar Competition

Avastin, Rituxan and Herceptin All Face Challengers

 
• By Dean Rudge
  
Roche
Roche acknowledges competition this year will be significant • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products